Validation of a PRO-CTCAE questionnaire for multiple myeloma patients.

Validation of a PRO-CTCAE questionnaire for multiple myeloma patients. - PRO-CTCAE-MM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022488

Enrollment

300

Registered

2020-08-24

Start date

2020-12-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90.0

Interventions

Group 1: Patients with multiple myeloma are asked once about their symptoms and quality of life.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients with multiple myeloma who are physically and mentally capable of independently completing the electronic patient questionnaire and who have an electronic consent form.

Exclusion criteria

Exclusion criteria: Patients with insufficient knowledge of the German language.

Design outcomes

Primary

Measure	Time frame
Validity (principal component analysis with varimax rotation, multitrait-multimethod matrix), after end of study, statistical analysis	—

Secondary

Measure	Time frame
Reliability (Cronbach's alpha), after end of study, statistical analysis	—

Countries

Germany

Contacts

Public ContactWolfgang Fehrmann

Pharmazeutisches Institut

w.fehrmann@uni-bonn.de0228/734943

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026